express scripts semaglutide coverage Express Scripts Changes GLP-1 Medication Coverage Policy Express Scripts Coverage, FDA Label

Retatrutide is an investigational once-weekly triple agonist that targets GLP-1, GIP, and glucagon receptors

What about its partner in crime

What the evidence does not show No large, independent, placebo-controlled trials

Any observed cortisol changes are likely secondary to metabolic improvements such as weight loss and enhanced insulin sensitivity

Proper refrigeration preserves potency for up to 28 days

Medical Considerations for Breastfeeding Mothers Seeking Weight Loss Treatment Postpartum weight management remains a legitimate health goal, and avoiding all therapeutic options during breastfeeding may not serve maternal wellbeing either